Effect of Bifidobacteriuminfantis on Interferon- γ- Induced Keratinocyte Apoptosis: A Potential Therapeutic Approach to Skin Immune Abnormalities
Authors:
- 1 October 2006
- journal article
- Published by SAGE Publications in International Journal of Immunopathology and Pharmacology
- Vol. 19 (4) , 775-786
Abstract
Current management of atopic dermatitis is mainly directed to the reduction of cutaneous inflammation. Since patients with atopic dermatitis show abnormalities in immunoregulation, a therapy aimed to adjust their immune function could represent an alternative approach, particularly in the severe form of the disease. Indeed, T-lymphocytes constitute a large population of cellular infiltrate in atopic/allergic inflammation and a dysregulated T-cell induced keratinocyte apoptosis appears to be an important pathogenetic factor of the eczematous disease. In recent years, attention has been focused on the interaction between host and probiotics which may have anti-inflammatory properties and immunomodulatory activities. The aim of the present work is to investigate the effect of a selected probiotic extract, the Bifidobacterium infantis extract, on a human keratinocyte cell line (HaCaT) abnormal apoptosis induced by activated-T-lymphocyte. An in vitro model of atopic dermatitis was used to assess the ability of the probiotic extract to protect HaCaT from apoptosis induced by soluble factors (IFN-γ and CD95 ligand) released by human T-lymphocytes in vitro activated with anti-CD3/CD28 mAbs or Phytohemoagglutinin. Evidence is given that the bacterial extract treatment was able to totally prevent T lymphocyte-induced HaCaT cell apoptosis in vitro. The mechanism underlying this inhibitory effect has been suggested to depend on the ability of the bacterial extract to significantly reduce anti-CD3/CD28 mAbs and mitogen-induced T-cell proliferation, IFN-γ generation and CD95 ligand release. These preliminary results may represent an experimental basis for a potential therapeutic approach mainly targeting the skin disorders-associated immune abnormalities.Keywords
This publication has 34 references indexed in Scilit:
- Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitisJournal of Allergy and Clinical Immunology, 2001
- Allergy development and the intestinal microflora during the first year of lifeJournal of Allergy and Clinical Immunology, 2001
- The role of lymphocytes in healthy and eczematous skinCurrent Opinion in Allergy and Clinical Immunology, 2001
- Nonclinical and early clinical development of tacrolimus ointment for the treatment of atopic dermatitisJournal of the American Academy of Dermatology, 2001
- T cell–mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitisJournal of Clinical Investigation, 2000
- Immunity and probioticsImmunology Today, 1999
- Comparison of Two Formulations of Cyclosporin A in the Treatment of Severe Atopic DermatitisDermatology, 1999
- Keratinocytes constitutively express the Fas antigen that mediates apoptosis in IFN?-treated cultured keratinocytesArchives of Dermatological Research, 1995
- Expression of Fas Antigen on Keratinocytes In Vivo and Induction of Apoptosis in Cultured KeratinocytesJournal of Investigative Dermatology, 1994
- Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.Journal of Cell Biology, 1988